Zydus Lifesciences Statistics

Total Valuation

BOM:532321 has a market cap or net worth of INR 981.03 billion. The enterprise value is 959.13 billion.

Market Cap	981.03B
Enterprise Value	959.13B

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	1.01B
Shares Outstanding	n/a
Shares Change (YoY)	-0.55%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	249.06M

Valuation Ratios

The trailing PE ratio is 21.68 and the forward PE ratio is 21.56.

PE Ratio	21.68
Forward PE	21.56
PS Ratio	4.22
PB Ratio	3.72
P/TBV Ratio	6.33
P/FCF Ratio	19.37
P/OCF Ratio	14.48
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.79, with an EV/FCF ratio of 18.94.

EV / Earnings	21.19
EV / Sales	4.13
EV / EBITDA	13.79
EV / EBIT	15.89
EV / FCF	18.94

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.12.

Current Ratio	1.89
Quick Ratio	1.31
Debt / Equity	0.12
Debt / EBITDA	0.47
Debt / FCF	0.63
Interest Coverage	36.04

Financial Efficiency

Return on equity (ROE) is 19.28% and return on invested capital (ROIC) is 14.24%.

Return on Equity (ROE)	19.28%
Return on Assets (ROA)	11.24%
Return on Invested Capital (ROIC)	14.24%
Return on Capital Employed (ROCE)	21.23%
Revenue Per Employee	8.63M
Profits Per Employee	1.68M
Employee Count	26,921
Asset Turnover	0.70
Inventory Turnover	1.72

Taxes

In the past 12 months, BOM:532321 has paid 14.12 billion in taxes.

Income Tax	14.12B
Effective Tax Rate	23.20%

Stock Price Statistics

The stock price has decreased by -10.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.53%
50-Day Moving Average	898.76
200-Day Moving Average	965.57
Relative Strength Index (RSI)	71.52
Average Volume (20 Days)	58,947

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532321 had revenue of INR 232.42 billion and earned 45.26 billion in profits. Earnings per share was 44.97.

Revenue	232.42B
Gross Profit	169.04B
Operating Income	59.79B
Pretax Income	60.85B
Net Income	45.26B
EBITDA	68.95B
EBIT	59.79B
Earnings Per Share (EPS)	44.97

Full Income Statement

Balance Sheet

The company has 78.08 billion in cash and 32.13 billion in debt, giving a net cash position of 45.95 billion.

Cash & Cash Equivalents	78.08B
Total Debt	32.13B
Net Cash	45.95B
Net Cash Per Share	n/a
Equity (Book Value)	263.58B
Book Value Per Share	238.12
Working Capital	80.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 67.77 billion and capital expenditures -17.13 billion, giving a free cash flow of 50.64 billion.

Operating Cash Flow	67.77B
Capital Expenditures	-17.13B
Free Cash Flow	50.64B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.73%, with operating and profit margins of 25.73% and 19.47%.

Gross Margin	72.73%
Operating Margin	25.73%
Pretax Margin	26.18%
Profit Margin	19.47%
EBITDA Margin	29.67%
EBIT Margin	25.73%
FCF Margin	21.79%

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.12%.

Dividend Per Share	11.00
Dividend Yield	1.12%
Dividend Growth (YoY)	266.67%
Years of Dividend Growth	n/a
Payout Ratio	6.68%
Buyback Yield	0.55%
Shareholder Yield	1.67%
Earnings Yield	4.61%
FCF Yield	5.16%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.

Last Split Date	Oct 6, 2015
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5